The most common side effects of INVEGA HAFYERA® include: injection site reactions, weight gain, headache, upper respiratory ...

The U.S. Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic ...

Psychedelics have been growing in popularity across North America for recreational and therapeutic use, with celebrities like ...

The scientists asked about 40 study participants—a mixture of neurotypical individuals and patients with schizophrenia—to ...

Art therapy can help individuals express thoughts and feelings without relying solely on words, providing a valuable outlet ...

Researchers have identified a potential diagnostic tool for schizophrenia by measuring brain cell activity between the ...

Psychosis affects one's physical, psychological, social, and existential health. Mental health recovery often involves a ...

Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the ...

Individuals with emergency department visits involving hallucinogen use are at high risk of developing schizophrenia, ...

Shares in AbbVie slumped Monday after the company disclosed its psychiatric medicine emraclidine didn’t best placebo in two ...

Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...